texas oncology more breakthroughs. more victories
Over 100 Texans have become sick with measles recently. To protect our patients and staff, we ask that patients and caregivers avoid coming in to our clinics if they have been near someone with measles, have been diagnosed with measles, or have any symptoms of infection like a fever or a rash. If any of these apply to you and you have a visit booked, please contact your clinic to let them know and book a virtual visit (telehealth) instead. Learn more about how to recognize measles and what you can do to stay safe. View More Important Notifications x

Katherine Wang, M.D., Ph.D.

Katherine Wang, M.D., Ph.D. Photo

Provider Type: Physician

Specialties:
Board Certifications:
  • Hematology
  • Internal Medicine
  • Medical Oncology

Downloads

General Summary

Katherine Wang, M.D., Ph.D. serves on the Hematology Committee for The US Oncology Network. She has designed several clinical trials in cancer therapy and has many publications. Her interest is in hematological malignancies, solid tumors and clinical trials.

Education

Dr. Wang attended medical school at Shanghai Medical University in Shanghai, China. She then received her Ph.D. in Immunology at Baylor College of Medicine in Houston, Texas in 2000 and did her combined Fellowship in Hematology and Oncology at The University of Texas MD Anderson Cancer Center and The University of Texas in Houston.

Accolades & Memberships

In 2005, Dr. Wang received the following awards: The Carol Cogdell Courtney Fellowship Annual Award, MD Anderson Trainee Excellence Award, Bristol-Myers Squibb Award in Clinic Translational Research, 1st Place poster presentation and the Chiron Fellowship Award for Translational Research in melanoma. American Society of Clinical Oncology, American Society of Hematology, Dallas County Medical Society and Texas medical Association. Dr. Wang designed several phase I/II clinical trails in cancer immunotherapy and has numerous publications on these studies. Her interest is in hematological malignancies, solid tumors and clinical trials.